-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Reiterates Strong Buy on Haemonetics, Lowers Price Target to $105

Benzinga·05/09/2025 16:14:53
Listen to the news
Raymond James analyst Andrew Cooper reiterates Haemonetics (NYSE:HAE) with a Strong Buy and lowers the price target from $115 to $105.